메뉴 건너뛰기




Volumn 13, Issue , 2013, Pages

Improving physical health and reducing substance use in psychosis - randomised control trial (IMPACT RCT): Study protocol for a cluster randomised controlled trial

Author keywords

Health promotion; Metabolic syndrome; Psychosis; Randomised controlled trial; Schizophrenia; Severe mental illness

Indexed keywords

ALCOHOL; CANNABIS; REDUCING AGENT;

EID: 84885454858     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-263     Document Type: Article
Times cited : (29)

References (73)
  • 1
    • 28844485754 scopus 로고    scopus 로고
    • Schizophrenia and increased risks of cardiovascular disease
    • Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150(6):1115-1121.
    • (2005) Am Heart J , vol.150 , Issue.6 , pp. 1115-1121
    • Hennekens, C.H.1    Hennekens, A.R.2    Hollar, D.3    Casey, D.E.4
  • 2
    • 76749116238 scopus 로고    scopus 로고
    • Twenty-five year mortality of a community cohort with schizophrenia
    • Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010, 196(2):116-121.
    • (2010) Br J Psychiatry , vol.196 , Issue.2 , pp. 116-121
    • Brown, S.1    Kim, M.2    Mitchell, C.3    Inskip, H.4
  • 3
    • 70350769112 scopus 로고    scopus 로고
    • Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors
    • Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry 2009, 31(6):555-563.
    • (2009) Gen Hosp Psychiatry , vol.31 , Issue.6 , pp. 555-563
    • Kilbourne, A.M.1    Morden, N.E.2    Austin, K.3    Ilgen, M.4    McCarthy, J.F.5    Dalack, G.6    Blow, F.C.7
  • 4
    • 59649114070 scopus 로고    scopus 로고
    • Premature mortality from general medical illnesses among persons with bipolar disorder: a review
    • Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv 2009, 60(2):147-156.
    • (2009) Psychiatr Serv , vol.60 , Issue.2 , pp. 147-156
    • Roshanaei-Moghaddam, B.1    Katon, W.2
  • 5
    • 0033830383 scopus 로고    scopus 로고
    • Causes of the excess mortality of schizophrenia
    • Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000, 177:212-217.
    • (2000) Br J Psychiatry , vol.177 , pp. 212-217
    • Brown, S.1    Inskip, H.2    Barraclough, B.3
  • 6
    • 80051792339 scopus 로고    scopus 로고
    • Life expectancy among persons with schizophrenia or bipolar affective disorder
    • Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011, 131(1-3):101-104.
    • (2011) Schizophr Res , vol.131 , Issue.1-3 , pp. 101-104
    • Laursen, T.M.1
  • 8
    • 0036280163 scopus 로고    scopus 로고
    • Mortality of patients with mood disorders: follow-up over 34-38 years
    • Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002, 68(2-3):167-181.
    • (2002) J Affect Disord , vol.68 , Issue.2-3 , pp. 167-181
    • Angst, F.1    Stassen, H.H.2    Clayton, P.J.3    Angst, J.4
  • 9
    • 33846882362 scopus 로고    scopus 로고
    • Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the united kingdoms general practice research database
    • Osborn DJ, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the united kingdoms general practice research database. Arch Gen Psychiatry 2007, 64(2):242-249.
    • (2007) Arch Gen Psychiatry , vol.64 , Issue.2 , pp. 242-249
    • Osborn, D.J.1    Levy, G.2    Nazareth, I.3    Petersen, I.4    Islam, A.5    King, M.B.6
  • 10
    • 34948840329 scopus 로고    scopus 로고
    • A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
    • Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64(10):1123-1131.
    • (2007) Arch Gen Psychiatry , vol.64 , Issue.10 , pp. 1123-1131
    • Saha, S.1    Chant, D.2    McGrath, J.3
  • 11
    • 27744502054 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
    • McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Scott Stroup T, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005, 80(1):19-32.
    • (2005) Schizophr Res , vol.80 , Issue.1 , pp. 19-32
    • McEvoy, J.P.1    Meyer, J.M.2    Goff, D.C.3    Nasrallah, H.A.4    Davis, S.M.5    Sullivan, L.6    Meltzer, H.Y.7    Hsiao, J.8    Scott Stroup, T.9    Lieberman, J.A.10
  • 12
  • 13
    • 25144459980 scopus 로고    scopus 로고
    • The metabolic syndrome-a new worldwide definition
    • Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
    • (2005) Lancet , vol.366 , Issue.9491 , pp. 1059-1062
    • Alberti, K.G.1    Zimmet, P.2    Shaw, J.3
  • 14
    • 33846365989 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies
    • Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49(4):403-414.
    • (2007) J Am Coll Cardiol , vol.49 , Issue.4 , pp. 403-414
    • Gami, A.S.1    Witt, B.J.2    Howard, D.E.3    Erwin, P.J.4    Gami, L.A.5    Somers, V.K.6    Montori, V.M.7
  • 15
    • 28944434431 scopus 로고    scopus 로고
    • Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus
    • Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005, 165(22):2644-2650.
    • (2005) Arch Intern Med , vol.165 , Issue.22 , pp. 2644-2650
    • Wannamethee, S.G.1    Shaper, A.G.2    Lennon, L.3    Morris, R.W.4
  • 16
    • 57449083235 scopus 로고    scopus 로고
    • The metabolic syndrome and schizophrenia
    • Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 2009, 119(1):4-14.
    • (2009) Acta Psychiatr Scand , vol.119 , Issue.1 , pp. 4-14
    • Meyer, J.M.1    Stahl, S.M.2
  • 17
    • 33646814409 scopus 로고    scopus 로고
    • Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs
    • Correll CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 2006, 67(4):575-583.
    • (2006) J Clin Psychiatry , vol.67 , Issue.4 , pp. 575-583
    • Correll, C.U.1    Frederickson, A.M.2    Kane, J.M.3    Manu, P.4
  • 18
    • 54549127387 scopus 로고    scopus 로고
    • Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis
    • Osborn DP, Wright CA, Levy G, King MB, Deo R, Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 2008, 8(84):8-84.
    • (2008) BMC Psychiatry , vol.8 , Issue.84 , pp. 8-84
    • Osborn, D.P.1    Wright, C.A.2    Levy, G.3    King, M.B.4    Deo, R.5    Nazareth, I.6
  • 19
    • 18744366088 scopus 로고    scopus 로고
    • Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
    • Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 1:1-93.
    • (2005) CNS Drugs , vol.1 , pp. 1-93
    • Newcomer, J.W.1
  • 20
    • 79952061062 scopus 로고    scopus 로고
    • Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis
    • Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011, 68(6):609-616.
    • (2011) Arch Gen Psychiatry , vol.68 , Issue.6 , pp. 609-616
    • Foley, D.L.1    Morley, K.I.2
  • 21
    • 84856466929 scopus 로고    scopus 로고
    • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    • De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011, 8(2):114-126.
    • (2011) Nat Rev Endocrinol , vol.8 , Issue.2 , pp. 114-126
    • De Hert, M.1    Detraux, J.2    van Winkel, R.3    Yu, W.4    Correll, C.U.5
  • 22
    • 77952671348 scopus 로고    scopus 로고
    • Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
    • Bobes J, Arango C, Garcia-Garcia M, Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010, 119(1-3):101-109.
    • (2010) Schizophr Res , vol.119 , Issue.1-3 , pp. 101-109
    • Bobes, J.1    Arango, C.2    Garcia-Garcia, M.3    Rejas, J.4
  • 23
    • 77952669440 scopus 로고    scopus 로고
    • Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia
    • Vancampfort D, Knapen J, Probst M, van Winkel R, Deckx S, Maurissen K, Peuskens J, De Hert M. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Res 2010, 177(3):271-279.
    • (2010) Psychiatry Res , vol.177 , Issue.3 , pp. 271-279
    • Vancampfort, D.1    Knapen, J.2    Probst, M.3    van Winkel, R.4    Deckx, S.5    Maurissen, K.6    Peuskens, J.7    De Hert, M.8
  • 24
    • 71549170209 scopus 로고    scopus 로고
    • Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial
    • Alvarez-Jimenez M, Martinez-Garcia O, Perez-Iglesias R, Ramirez ML, Vazquez-Barquero JL, Crespo-Facorro B. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res 2010, 116(1):16-19.
    • (2010) Schizophr Res , vol.116 , Issue.1 , pp. 16-19
    • Alvarez-Jimenez, M.1    Martinez-Garcia, O.2    Perez-Iglesias, R.3    Ramirez, M.L.4    Vazquez-Barquero, J.L.5    Crespo-Facorro, B.6
  • 27
    • 84867670653 scopus 로고    scopus 로고
    • The cardiovascular health of young people with severe mental illness: addressing an epidemic within an epidemic
    • Bailey S, Gerada C, Lester H, Shiers D. The cardiovascular health of young people with severe mental illness: addressing an epidemic within an epidemic. Psychiatrist 2012, 36(10):375-378.
    • (2012) Psychiatrist , vol.36 , Issue.10 , pp. 375-378
    • Bailey, S.1    Gerada, C.2    Lester, H.3    Shiers, D.4
  • 29
    • 20444463577 scopus 로고    scopus 로고
    • A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
    • de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia research 2005, 76(2):135-157.
    • (2005) Schizophrenia research , vol.76 , Issue.2 , pp. 135-157
    • de Leon, J.1    Diaz, F.J.2
  • 31
    • 0025226205 scopus 로고
    • Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study
    • Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Jama 1990, 264(19):2511-2518.
    • (1990) Jama , vol.264 , Issue.19 , pp. 2511-2518
    • Regier, D.A.1    Farmer, M.E.2    Rae, D.S.3    Locke, B.Z.4    Keith, S.J.5    Judd, L.L.6    Goodwin, F.K.7
  • 32
    • 33748513029 scopus 로고    scopus 로고
    • Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999
    • Boydell J, van Os J, Caspi A, Kennedy N, Giouroukou E, Fearon P, Farrell M, Murray RM. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol Med 2006, 36(10):1441-1446.
    • (2006) Psychol Med , vol.36 , Issue.10 , pp. 1441-1446
    • Boydell, J.1    van Os, J.2    Caspi, A.3    Kennedy, N.4    Giouroukou, E.5    Fearon, P.6    Farrell, M.7    Murray, R.M.8
  • 34
    • 34447619511 scopus 로고    scopus 로고
    • Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
    • Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
    • (2007) Lancet , vol.370 , Issue.9584 , pp. 319-328
    • Moore, T.H.1    Zammit, S.2    Lingford-Hughes, A.3    Barnes, T.R.4    Jones, P.B.5    Burke, M.6    Lewis, G.7
  • 37
    • 0028316414 scopus 로고
    • Cannabis abuse and the course of recent-onset schizophrenic disorders
    • Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994, 51(4):273-279.
    • (1994) Arch Gen Psychiatry , vol.51 , Issue.4 , pp. 273-279
    • Linszen, D.H.1    Dingemans, P.M.2    Lenior, M.E.3
  • 38
    • 17644416418 scopus 로고    scopus 로고
    • Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care
    • Isaac M, Holloway F. Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. Hum Psychopharmacol 2005, 20(3):207-210.
    • (2005) Hum Psychopharmacol , vol.20 , Issue.3 , pp. 207-210
    • Isaac, M.1    Holloway, F.2
  • 39
    • 3042558516 scopus 로고    scopus 로고
    • Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking
    • Haddock CK, Lando H, Klesges RC, Peterson AL, Scarinci IC. Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking. Am J Prev Med 2004, 27(1):35-41.
    • (2004) Am J Prev Med , vol.27 , Issue.1 , pp. 35-41
    • Haddock, C.K.1    Lando, H.2    Klesges, R.C.3    Peterson, A.L.4    Scarinci, I.C.5
  • 40
    • 0035181906 scopus 로고    scopus 로고
    • An investigation of models of illness in carers of schizophrenia patients using the illness perception questionnaire
    • Barrowclough C, Lobban F, Hatton C, Quinn J. An investigation of models of illness in carers of schizophrenia patients using the illness perception questionnaire. Br J Clin Psychol 2001, 40(Pt 4):371-385.
    • (2001) Br J Clin Psychol , vol.40 , Issue.PART 4 , pp. 371-385
    • Barrowclough, C.1    Lobban, F.2    Hatton, C.3    Quinn, J.4
  • 41
    • 78649855189 scopus 로고    scopus 로고
    • Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial
    • Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ 2010, 341:c6325.
    • (2010) BMJ , vol.341
    • Barrowclough, C.1    Haddock, G.2    Wykes, T.3    Beardmore, R.4    Conrod, P.5    Craig, T.6    Davies, L.7    Dunn, G.8    Eisner, E.9    Lewis, S.10
  • 44
    • 0035906286 scopus 로고    scopus 로고
    • Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation
    • Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama 2001, 285(15):1992-1995.
    • (2001) Jama , vol.285 , Issue.15 , pp. 1992-1995
    • Moher, D.1    Jones, A.2    Lepage, L.3
  • 45
    • 1642400145 scopus 로고    scopus 로고
    • CONSORT statement: extension to cluster randomised trials
    • Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328(7441):702-708.
    • (2004) BMJ , vol.328 , Issue.7441 , pp. 702-708
    • Campbell, M.K.1    Elbourne, D.R.2    Altman, D.G.3
  • 47
    • 0002623347 scopus 로고
    • Timeline Follow-Back
    • Humana Press, Litten R, Allen J
    • Sobell L, Sobell M. Timeline Follow-Back. Measuring Alcohol Consumption 1992, 41-72. Humana Press, Litten R, Allen J.
    • (1992) Measuring Alcohol Consumption , pp. 41-72
    • Sobell, L.1    Sobell, M.2
  • 48
    • 0024338367 scopus 로고
    • Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire
    • Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 1989, 12(2):159-182.
    • (1989) J Behav Med , vol.12 , Issue.2 , pp. 159-182
    • Fagerstrom, K.O.1    Schneider, N.G.2
  • 49
    • 0018240502 scopus 로고
    • Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
    • Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978, 3(3-4):235-241.
    • (1978) Addict Behav , vol.3 , Issue.3-4 , pp. 235-241
    • Fagerstrom, K.O.1
  • 50
    • 0027154845 scopus 로고
    • Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II
    • Saunders JB, Aasland OG, Babor TF, DeLaFuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 1993, 88:617-629.
    • (1993) Addiction , vol.88 , pp. 617-629
    • Saunders, J.B.1    Aasland, O.G.2    Babor, T.F.3    DeLaFuente, J.R.4    Grant, M.5
  • 51
    • 0028580624 scopus 로고
    • Dietary intervention in primary care: validity of the DINE method for diet assessment
    • Roe L, Strong C, Whiteside C, Neil A, Mant D. Dietary intervention in primary care: validity of the DINE method for diet assessment. Fam Pract 1994, 11(4):375-381.
    • (1994) Fam Pract , vol.11 , Issue.4 , pp. 375-381
    • Roe, L.1    Strong, C.2    Whiteside, C.3    Neil, A.4    Mant, D.5
  • 53
    • 0024760391 scopus 로고
    • The positive and negative syndrome scale (PANSS): rationale and standardisation
    • Kay SR, Opler LA, Lindenmayer JP. The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl 1989, 7:59-67.
    • (1989) Br J Psychiatry Suppl , vol.7 , pp. 59-67
    • Kay, S.R.1    Opler, L.A.2    Lindenmayer, J.P.3
  • 55
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
    • (1979) Br J Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.A.1    Asberg, M.2
  • 56
    • 0026410654 scopus 로고
    • A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system
    • McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991 Aug, 48(8):764-770.
    • (1991) Arch Gen Psychiatry , vol.48 , Issue.8 , pp. 764-770
    • McGuffin, P.1    Farmer, A.2    Harvey, I.3
  • 57
    • 0030048806 scopus 로고    scopus 로고
    • Compliance therapy in psychotic patients: randomised controlled trial
    • Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996, 312(7027):345-349.
    • (1996) BMJ , vol.312 , Issue.7027 , pp. 345-349
    • Kemp, R.1    Hayward, P.2    Applewhaite, G.3    Everitt, B.4    David, A.5
  • 58
    • 0029044513 scopus 로고
    • A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients
    • Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 1995, 166(5):650-653.
    • (1995) Br J Psychiatry , vol.166 , Issue.5 , pp. 650-653
    • Day, J.C.1    Wood, G.2    Dewey, M.3    Bentall, R.P.4
  • 59
    • 0033937434 scopus 로고    scopus 로고
    • Client socio-demographic and service receipt inventory - European version : development of an instrument for international research: EPSILON Study 5
    • Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Van Wijngaarden B, Group ES. Client socio-demographic and service receipt inventory - European version : development of an instrument for international research: EPSILON Study 5. Br J Psychiatry 2000, 177(39):s28-s33.
    • (2000) Br J Psychiatry , vol.177 , Issue.39
    • Chisholm, D.1    Knapp, M.R.J.2    Knudsen, H.C.3    Amaddeo, F.4    Gaite, L.5    Van Wijngaarden, B.6    Group, E.S.7
  • 61
    • 33846199137 scopus 로고    scopus 로고
    • Developments in cluster randomized trials and statistics in medicine
    • Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and statistics in medicine. Stat Med 2007, 26(1):2-19.
    • (2007) Stat Med , vol.26 , Issue.1 , pp. 2-19
    • Campbell, M.J.1    Donner, A.2    Klar, N.3
  • 62
    • 18344381003 scopus 로고    scopus 로고
    • Design and analysis of clinical trials with clustering effects due to treatment
    • Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials 2005, 2(2):152-162.
    • (2005) Clin Trials , vol.2 , Issue.2 , pp. 152-162
    • Roberts, C.1    Roberts, S.A.2
  • 65
    • 32444450470 scopus 로고    scopus 로고
    • Multiple imputation of missing values: update
    • Royston P. Multiple imputation of missing values: update. Stata J 2005, 5(2):188-201.
    • (2005) Stata J , vol.5 , Issue.2 , pp. 188-201
    • Royston, P.1
  • 67
    • 85130029608 scopus 로고    scopus 로고
    • Multiple imputation of multilevel data
    • UK: Routledge, Hox JJ, Roberts JK, Milton P
    • van Buuren S. Multiple imputation of multilevel data. The Handbook of Advanced Multilevel Analysis(10) 2011, 173-196. UK: Routledge, Hox JJ, Roberts JK, Milton P.
    • (2011) The Handbook of Advanced Multilevel Analysis(10) , pp. 173-196
    • van Buuren, S.1
  • 68
    • 79955417678 scopus 로고    scopus 로고
    • Strategy for intention to treat analysis in randomised trials with missing outcome data
    • White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011, 7(342):d40.
    • (2011) BMJ , vol.7 , Issue.342
    • White, I.R.1    Horton, N.J.2    Carpenter, J.3    Pocock, S.J.4
  • 69
    • 24944584791 scopus 로고    scopus 로고
    • Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods
    • Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 2005, 14(4):369-395.
    • (2005) Stat Methods Med Res , vol.14 , Issue.4 , pp. 369-395
    • Dunn, G.1    Maracy, M.2    Tomenson, B.3
  • 70
    • 0036169017 scopus 로고    scopus 로고
    • The estimation of a preference-based measure of health from the SF-36
    • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21(2):271-292.
    • (2002) J Health Econ , vol.21 , Issue.2 , pp. 271-292
    • Brazier, J.1    Roberts, J.2    Deverill, M.3
  • 71
    • 0028509556 scopus 로고
    • Costs, effects and C/E-ratios alongside a clinical trial
    • van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994, 3(5):309-319.
    • (1994) Health Econ , vol.3 , Issue.5 , pp. 309-319
    • van Hout, B.A.1    Al, M.J.2    Gordon, G.S.3    Rutten, F.F.4
  • 73
    • 84865335577 scopus 로고    scopus 로고
    • Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials
    • Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res 2012, 140(1-3):159-168.
    • (2012) Schizophr Res , vol.140 , Issue.1-3 , pp. 159-168
    • Caemmerer, J.1    Correll, C.U.2    Maayan, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.